Low serum 25-hydroxyvitamin D [25(OH)D] concentrations in type 2 diabetes mellitus patients presenting to a functional medicine clinic

Paul A. Oakley, Stephanie J. Chaney, Michael A. Persinger, Thomas A. Chaney

Behavioral Neuroscience Program, Laurentian University, Sudbury, Canada.
Private Practice, Annapolis, USA.
Private Practice, Newmarket, Canada.

DOI: 10.4236/jbise.2013.65A003                

Abstract

This study explores the relationship of 25-hydroxylvitamin D blood levels in 106 randomly selected patient files with diagnosed type 2 Diabetes Mellitus (t2DM) who enrolled in a functional medicine diabetes reversal program from a chiropractic clinic located in Annapolis, Maryland, USA. Using a conservative recommendation for normal serum 25-hydroxyvitamin D concentration of 32 ng/ml, insufficiency level of 20 - 30 ng/ml, and deficiency level < 20 ng/ml, 21% (22/106) of our population were normal, 39% (41/106) were insufficient, and alarmingly, 35% (37/106) were outright deficient. Clinically, 74% (78/ 106) of our entire sample had significantly low vitamin D levels. Ou et al. (2011) determined the optimal concentration of serum 25OHD to be 40 ng/ml in order to optimize insulin sensitivity. In our sample 100/ 106 (94%) had vitamin D levels at or below this optimal cut-off level. BMI was negatively correlated with vitamin D; that is, the greater the BMI of the patient the less their vitamin D level. Both obesity and hypovitaminosis D are each mutually exclusive predictors for t2DM. Obesity and vitamin D deficiency may work synergistically to propel an individual into the diseased state of t2DM. As this study demonstrates that the majority of people with t2DM suffer from inadequate amounts of vitamin D, vitamin D testing should be routine for all people at risk for t2DM, prediabetics and those currently suffering with t2DM in order to elevate levels sufficiently to improve insulin sensitivity and improve long-term outcomes.

Keywords

Diabetes Mellitus; BMI; Vitamin D; Deficiency; Insufficiency; Functional Medicine

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Kahn, H., Kunutsor, S., Franco, O.H. and Chowdhury, R. (2013) Vitamin D, type 2 diabetes and other metabolic outcomes: A systematic review and meta-analysis of prospective studies. Proceedings of the Nutrition Society, 72, 89-97. doi:10.1017/S0029665112002765
[2]	Yu, J.R., Lee, S.A., Lee, J.G., Seong, G.M., Ko, S.J., Koh, G., et al. (2010) Serum vitamin D status and its relationship to metabolic parameters in patients with type 2 diabetes mellitus. Chonnam Medical Journal, 48, 108-115. doi:10.4068/cmj.2012.48.2.108
[3]	Hollis, B.W. (2005) Circulating 25-hydroxyvitamin levels indicative of vitamin D sufficiency: Implications for establishing a new effective dietary intake recommendation for vitamin D. Journal of Nutrition, 135, 317-22.
[4]	Holick, M.F. (2008) Diabetes and the vitamin D connection. Current Diabetes Reports, 8, 393-398. doi:10.1007/s11892-008-0068-0
[5]	(2010) Standing committee on the scientific evaluation of dietary reference intakes. Dietary reference intakes for vitamin D and calcium. National Academy Press, Washington DC.
[6]	Scragg, R., Holdaway, I., Singh, V., Metcalf, P., Baker, J. and Dryson, E. (1995) Serum 25-hydroxyvitamin D3 levels decreased in impaired glucose tolerance and diabetes mellitus. Diabetes Research and Clinical Practice, 27, 181-188. doi:10.1016/0168-8227(95)01040-K
[7]	Pietschmann, P., Schernthaner, G. and Woloszczuk, W. (1988) Serum osteocalcin levels in diabetes mellitus: Analysis of the type of diabetes and microvascular complications. Diabetologia, 31, 892-895. doi:10.1007/BF00265373
[8]	Isaia, G., Giorgino, R. and Adami, S. (2001) High prevalence of hypovitaminosis D in female type 2 diabetic population. Diabetes Care, 24, 1496. doi:10.2337/diacare.24.8.1496
[9]	Joergensen, C., Gall, M.A., Schmedes, A., Tarnow, L., Parving, H.H. and Rossing, P. (2010) Vitamin D levels and mortality in type 2 diabetes. Diabetes Care, 33, 2238-2243. doi:10.2337/dc10-0582
[10]	McKenna, M.J. (1992) Differences in vitamin D status between countries in young adults and the elderly. American Journal of Medicine, 93, 69-77. doi:10.1016/0002-9343(92)90682-2
[11]	Abdul-Ghani, M.A., Tripathy, D. and DeFronzo, R.A. (2006) Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care, 29, 1130-1139. doi:10.2337/dc05-2179
[12]	Chiu, K.C., Chu, A., Go, V.L. and Saad, M.F. (2004) Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. The American Journal of Clinical Nutrition, 79, 820-825.
[13]	Rosetti, L., Giaccari, A. and DeFronzo, R.A. (1990) Glucose toxicity. Diabetes Care, 13, 610-630. doi:10.2337/diacare.13.6.610
[14]	Pittas, A.G., Dawson-Hughes, B., Li, T., Van Dam, R.M., Willett, W.C., Manson, J.E. and Hu, F.B. (2006) Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care, 29, 650-656. doi:10.2337/diacare.29.03.06.dc05-1961
[15]	Schwalfenberg, G. (2008) Vitamin D and diabetes. Canadian Family Physician, 54, 864-866.
[16]	Kumar, S., Davies, M., Zakaria, Y., Mawer, E.B., Gordon, C., Olukoga, A.O. and Boulton, A.J.M. (1994) Improvement in glucose tolerance and beta-cell function in a patient with vitamin D deficiency during treatment with vitamin. Postgraduate Medical Journal, 70, 440-443. doi:10.1136/pgmj.70.824.440
[17]	Chaney, S., Chaney, T. and Oakley, P.A. (2011) Functional medicine and chiropractic: A case series in type 2 diabetes mellitus reversal. Clinical Chiropractic, 14, 147148. doi:10.1016/j.clch.2011.09.007
[18]	Norman, A.W., Frankel, J.B., Heldt, A.M. and Grodsky, G.M. (1980) Vitamin D deficiency inhibits pancreatic secretion of insulin. Science, 209, 823-825. doi:10.1126/science.6250216
[19]	Teegarden, D. and Donkin, S.S. (2009) Vitamin D: Emerging new roles in insulin sensitivity. Nutrition Research Reviews, 22, 82-92. doi:10.1017/S0954422409389301
[20]	Peiris, A.N., Bailey, B.A., Peiris, P., Copeland, R.J. and Manning, T. (2011) Race and vitamin D status and monitoring in male veterans. Journal of the National Medical Association, 103, 492-497.
[21]	Garret-Mayer, E., Wagner, C.L., Hollis, B.W., Kindy, M.S. and Gattoni-Celli, S. (2012) Vitamin D3 supplemtation (4000 IU/d for 1y) eliminates differences in circu-lating 25-hydroxyvitamin D between African American and white men. The American Journal of Clinical Nutrition, 96, 332-336. doi:10.3945/ajcn.112.034256
[22]	NIH (2011) Dietary supplement fact sheet: Vitamin D. http://ods.od.nih.gov/factsheets/VitaminD-QuickFacts/
[23]	Gonzalez-Molero, I., Rojo-Martinez, G., Morcillo, S., Gutierrez, C., Rubio, E., Perez-Valero, V., et al. (2013) Hypovitaminosis D and incidence of obesity: A prospective study. European Journal of Nutrition, Epub Ahead of Print. doi:10.1038/ejcn.2013.48
[24]	Ou, H.Y., Karnchanasorn, R., Lee, L.Z. and Chiu, K.C. (2011) Interaction of BMI with vitamin D and insulin sensitivity. European Journal of Clinical Investigation, 41, 1195-1201. doi:10.1111/j.1365-2362.2011.02525.x
[25]	Inzucchi, S.E., Maggs, D.G., Spollett, G.R., Page, S.L., Rife, F.S., Walton, V., et al. (1998) Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. The New England Journal of Medicine, 338, 867-872. doi:10.1056/NEJM199803263381303
[26]	Pittas, A.G., Lau, J., Hu, F.B., and Dawson-Hughes, B. (2007) The role of vitamin D and calcium in type s diabetes. A systematic review and meta-analysis. The Journal of Clinical Endocrinology & Metabolism, 92, 20172029. doi:10.1210/jc.2007-0298
[27]	Boucher, B.J. (1998) Inadequate vitamin D status: Does it contribute to the disorders comprising syndrome “X”? British Journal of Nutrition, 79, 315-327.